JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M505951200 on October 28, 2005

J. Biol. Chem., Vol. 281, Issue 5, 2893-2900, February 3, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/5/2893    most recent
M505951200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parmeggiani, A.
Right arrow Articles by Nissen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parmeggiani, A.
Right arrow Articles by Nissen, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Enacyloxin IIa Pinpoints a Binding Pocket of Elongation Factor Tu for Development of Novel Antibiotics*Formula

Andrea Parmeggiani{ddagger}§1, Ivo M. Krab§2, Toshihiko Watanabe||, Rikke C. Nielsen{ddagger}, Caroline Dahlberg{ddagger}3, Jens Nyborg{ddagger}, and Poul Nissen{ddagger}4

From the {ddagger}Department of Molecular Biology, University of Aarhus, Gustav Wieds Vej 10 C, DK-8000 Aarhus C, Denmark, §Laboratoire de Biophysique, Ecole Polytechnique, F-91128 Palaiseau Cedex, France, Department of Chemistry, Leiden University, P.O. Box 9502, NL-2300 RA Leiden, The Netherlands, and ||Department of Civil Engineering, Tohoku Institute of Technology, Sendai 982-8577, Japan

Elongation factor (EF-) Tu·GTP is the carrier of aminoacyl-tRNA to the programmed ribosome. Enacyloxin IIa inhibits bacterial protein synthesis by hindering the release of EF-Tu·GDP from the ribosome. The crystal structure of the Escherichia coli EF-Tu·guanylyl iminodiphosphate (GDPNP)·enacyloxin IIa complex at 2.3 Å resolution presented here reveals the location of the antibiotic at the interface of domains 1 and 3. The binding site overlaps that of kirromycin, an antibiotic with a structure that is unrelated to enacyloxin IIa but that also inhibits EF-Tu·GDP release. As one of the major differences, the enacyloxin IIa tail borders a hydrophobic pocket that is occupied by the longer tail of kirromycin, explaining the higher binding affinity of the latter. EF-Tu·GDPNP·enacyloxin IIa shows a disordered effector region that in the Phe-tRNAPhe·EF-Tu (Thermus aquaticus)·GDPNP·enacyloxin IIa complex, solved at 3.1 Å resolution, is stabilized by the interaction with tRNA. This work clarifies the structural background of the action of enacyloxin IIa and compares its properties with those of kirromycin, opening new perspectives for structure-guided design of novel antibiotics.


Received for publication, June 1, 2005 , and in revised form, July 25, 2005.

The atomic coordinates and structure factors (code 2BVN and 1OB5) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* This work was supported by an Ole Rømer stipend, the Dansync Project of the Danish Natural Science Research Council, European Union Contract QLK2-CT-2002-00892, Grant 21-03-0214 from the Danish Natural Science Research Councils Centre for Structural Biology, and the European Molecular Biology Organization Young Investigator program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental material.

2 Present address: Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, 1955 East-West Rd., Ag. Sci. 218, Honolulu, HI 96822-2321.

3 Present address: Dept. of Biochemistry, University of Washington, Box 357350, Seattle, WA 98195-7350.

1 To whom correspondence may be addressed: Dept. of Molecular Biology, University of Aarhus, Gustav Wieds Vej 10 C, DK-8000 Aarhus C, Denmark. Tel.: 45-8942-5258; Fax: 45-8612-3178; E-mail: andrea{at}bioxray.dk.

4 To whom correspondence may be addressed. Tel.: 45-8942-5025; Fax: 45 8612 3178; E-mail: pn{at}mb.au.dk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
L. N. Olsthoorn-Tieleman, R.-J. T. S. Palstra, G. P. van Wezel, M. J. Bibb, and C. W. A. Pleij
Elongation Factor Tu3 (EF-Tu3) from the Kirromycin Producer Streptomyces ramocissimus Is Resistant to Three Classes of EF-Tu-Specific Inhibitors
J. Bacteriol., May 1, 2007; 189(9): 3581 - 3590.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.